Abstract
Gene therapy can be defined as the transfer of genetic material with therapeutic intent. Gene transfer has become clinically feasible as our understanding of the molecular basis of disease has matured and we have developed improved techniques for manipulating genetic material
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
General
Cornetta K, Matheson L, Ballas C. Retroviral vector production in the National Gene Vector Laboratory at Indiana University. Gene Ther. 2005;12:S28–S35.
Frampton A Jr, Goins W, Nakano K, Burton E, Glorioso J. HSV trafficking and development of gene therapy vectors with applications in the nervous system. Gene Ther. 2005;12:891–901.
McConnell MJ, Imperialge MJ. Biology of adenovirus and its use as a vector for gene therapy. Hum Gene Ther. 2004;15:1022–1033.
Muzyczka N, Warrington KH Jr. Custom adeno-associated virus capsids: The next generation of recombinant vectors with novel tropism. Hum Gene Ther. 2005;16:408–416.
Parekh-Olmedo H, Ferrara L, Brachman E, Kmiec EB. Gene therapy progress and prospects: targeted gene repair. Gene Ther. 2005;12:639–646.
Polak J, Hench L. Gene therapy progress and prospects: In tissue engineering. Gene Ther. 2005;12:1725–1733.
Sinn PL, Sauter SL, McCray PB Jr. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors-design, biosafety, and production. Gene Ther. 2005;12:1089–1098.
Verma IM, Weitzman MD. Gene therapy: twenty-first century medicine. Annual Rev Biochem. 2005;74:711–738.
Non-Viral Gene Transfer
Gleave M, Monia B. Antisense therapy for cancer. Nat Rev Cancer. 2005;5:468–479.
Glover D, Lipps H, Jans D. Towards safe, non-viral therapeutic gene expression in humans. Nat Rev Genet. 2005;6:299–310.
Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990;257:1465–1468.
Clinical Studies—Classic Papers and Recent Reviews
Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002;296:2410–2413.
Blaese RM, Culver KW, Miller AD, et al. T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 1995;270:475–480.
Brenner MK, Rill DR, Moen RC, et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993;341:85–86.
Carter B. Adeno-associated virus vectors in clinical trials. Hum Gene Ther. 2005;16:541–550.
Cornetta K, Smith FO. Regulatory issues for clinical gene therapy trials. Hum Gene Ther. 2002;13:1143–1149.
Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med. 2002;346:1185–1193.
Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2004;348:255, 256.
Nathwani A, Davidoff A, Linch D. A review of gene therapy for haematological disorders. Br J Haematol. 2004;128:3–17.
Peng Z. Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum Gene Ther. 2005;16:1016–1027.
Rosenberg SA, Aebersold P, Cornetta K, et al. Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med. 1990;323:570–578.
Strayer D, Akkina R, Bunnell B, et al. Current status of gene therapy strategies to treat HIV/AIDS. Mol Ther. 2005;11(6):823–842.
Cancer Gene Therapy
Abonour R, Williams DA, Einhorn E, et al. Efficient retroviral-mediated MDR-1 gene transfer into autologous human long-term repopulating hematopoietic stem cells. Nat Med. 2000;6:652–658
Aghi M, Martuza R. Oncolytic viral therapies-the clinical experience. Oncogene 2005;24:7802–7816.
Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony stimulating factor stimulates potent, long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993;90:3539–3543.
Gallo P, Dharmapuri S, Cipriani B, Monaci P. Adenovirus as vehicle for anticancer genetic immunotherapy. Gene Ther. 2005;12:S84–S91.
Kershaw M, Teng M, Smyth M, Darcy P. Supernatural T cells: genetic modification of T cells for cancer therapy. Nat Rev Immunol. 2005;5:928–940.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Cornetta, K. (2008). Gene Therapy. In: Cheng, L., Zhang, D.Y. (eds) Molecular Genetic Pathology. Humana Press. https://doi.org/10.1007/978-1-59745-405-6_29
Download citation
DOI: https://doi.org/10.1007/978-1-59745-405-6_29
Publisher Name: Humana Press
Print ISBN: 978-1-58829-974-1
Online ISBN: 978-1-59745-405-6
eBook Packages: MedicineMedicine (R0)